← Leaderboards
Ervin H Epstein
University Of California San Francisco
$10,578,782
Attributed
$10,578,782
Total exposure
13
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.5M · FY2005–16$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$21,086,435 · 15
By mechanism
R01$9,250,311 · 4
P01$6,341,518 · 4
U19$5,174,696 · 3
T32$215,728 · 1
M01$64,182 · 2
R13$40,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Rosemary J Akhurst$18,718,924
Others in their field
Top investigators on “Basal Cell Carcinoma”
- Anthony E Oro · Stanford University$19,778,107
- Margaret Rita Karagas · Dartmouth College$12,194,909
- Habibul Ahsan · Columbia University Health Sciences$11,863,792
- Philip A Beachy · Stanford University$11,655,326
- George L Sen · University Of California, San Diego$10,424,121
- Andrzej A Dlugosz · University Of Michigan At Ann Arbor$10,086,124
Research focus
Basal Cell CarcinomaChemopreventionMouse ModelMalignant NeoplasmsCarcinogenesisSmoothened Signaling PathwayMutationTissuesNevusCancer PreventionSkin CancerCellsResistanceSignal TransductionSkinTumorClinical ResearchStem CellsTumorigenesisNeoplasm /Cancer GeneticsRelative (Related Person)Chemopreventive AgentResearch StudyIn Vivo
Grant awards (54)
Basal cell carcinomas: p53-dependent mechanisms of resistance$336,150
R01 · FY2016 · CA · contact PI
Basal cell carcinomas: p53-dependent mechanisms of resistance$336,150
R01 · FY2015 · CA · contact PI
Basal cell carcinomas: p53-dependent mechanisms of resistance$326,066
R01 · FY2014 · CA · contact PI
Vitamin D3 Inhibition of Hedgehog Signaling and Cancer Chemoprevention$313,356
R01 · FY2014 · CA · contact PI
Basal cell carcinomas: p53-dependent mechanisms of resistance$315,981
R01 · FY2013 · CA · contact PI
Vitamin D3 Inhibition of Hedgehog Signaling and Cancer Chemoprevention$303,665
R01 · FY2013 · CA · contact PI
Basal cell carcinomas: p53-dependent mechanisms of resistance$336,150
R01 · FY2012 · CA · contact PI
Vitamin D3 Inhibition of Hedgehog Signaling and Cancer Chemoprevention$323,047
R01 · FY2012 · CA · contact PI
Vitamin D3 Inhibition of Hedgehog Signaling and Cancer Chemoprevention$323,047
R01 · FY2011 · CA · contact PI
Biology of Basal Cell Carcinomas$296,723
R01 · FY2011 · CA · contact PI
Vitamin D3 Inhibition of Hedgehog Signaling and Cancer Chemoprevention$333,038
R01 · FY2010 · CA · contact PI
Biology of Basal Cell Carcinomas$305,900
R01 · FY2010 · CA · contact PI
Chemoprevention of Basal Cell Carcinomas with Tazarotene$742,673
R01 · FY2009 · CA · contact PI
Biology of Basal Cell Carcinomas$305,900
R01 · FY2009 · CA · contact PI
Chemoprevention of Basal Cell Carcinomas with Tazarotene$1,005,301
R01 · FY2008 · CA · contact PI
Biology of Basal Cell Carcinomas$305,900
R01 · FY2008 · CA · contact PI
Chemoprevention of Basal Cell Carcinomas with Tazarotene$984,967
R01 · FY2007 · CA · contact PI
Skin Cancer in Organ Transplant Recipients$358,490
P01 · FY2007 · AR · contact PI
Biology of Basal Cell Carcinomas$305,900
R01 · FY2007 · CA · contact PI
Tissue Core$234,036
P01 · FY2007 · AR · contact PI
Administrative Core$96,627
P01 · FY2007 · AR · contact PI
Program Project Grant$1,334,506
P01 · FY2006 · AR · contact PI
Chemoprevention of Basal Cell Carcinomas with Tazarotene$139,221
R01 · FY2006 · CA · contact PI
Obstacles to Translating Basic Knowledge of Genetic Skin Disease into Therapies$25,000
R13 · FY2006 · AR · contact PI
Program Project Grant$1,461,558
P01 · FY2005 · AR
Chemoprevention of Basal Cell Carcinomas with Tazarotene$933,553
R01 · FY2005 · CA
BASAL CELL CARCINOMA CHEMOPREVENTION IN BCNS PATIENTS$99,966
U19 · FY2005 · CA
Obstacles to Translating Basic Knowledge of Genetic Skin Disease into Therapies$15,000
R13 · FY2005 · AR
A PHASE III TRIAL OF CELECOXIB IN BASAL CELL NEVUS SYNDROME$14,497
M01 · FY2005 · RR
GENETIC SUSCEPTIBILITY TO NON-MELANOMA SKIN CANCERS$14,030
M01 · FY2005 · RR
Program Project Grant$1,424,168
P01 · FY2004 · AR
Chemoprevention of Basal Cell Carcinomas with Tazarotene$677,623
R01 · FY2004 · CA
BASAL CELL CARCINOMA CHEMOPREVENTION IN BCNS PATIENTS$99,966
U19 · FY2004 · CA
Genetic Susceptibility to Non-Melanoma Skin Cancers$22,269
M01 · FY2004 · RR
A Phase III Trial of Celecoxib in Basal Cell Nevus Syndrome$13,386
M01 · FY2004 · RR
Program Project Grant$1,432,133
P01 · FY2003 · AR
BASAL CELL CARCINOMA CHEMOPREVENTION IN BCNS PATIENTS$1,354,185
U19 · FY2003 · CA
Core--Tissue$0
P01 · FY2003 · AR
Skin cancer in organ transplant recipients$0
P01 · FY2003 · AR
BASAL CELL CARCINOMA CHEMOPREVENTION IN BCNS PATIENTS$1,308,053
U19 · FY2002 · CA
CORE--BIOSTATISTICAL$0
U19 · FY2002 · CA
CHEMOPREVENTION OF BASAL CELL CARCINOMAS IN BCNS PATIENTS$0
U19 · FY2002 · CA
BASAL CELL CARCINOMA CHEMOPREVENTION IN BCNS PATIENTS$918,107
U19 · FY2001 · CA
DERMATOLOGY TRAINING GRANT - GRADUATE RESEARCH TRAINING$103,433
T32 · FY2001 · AR
BASAL CELL CARCINOMA CHEMOPREVENTION IN BCNS PATIENTS$51,750
U19 · FY2001 · CA
DERMATOLOGY TRAINING GRANT - GRADUATE RESEARCH TRAINING$17,491
T32 · FY2001 · AR
CHEMOPREVENTION OF BASAL CELL CARCINOMAS IN BCNS PATIENTS$0
U19 · FY2001 · CA
CHEMOPREVENTION OF BASAL CELL CARCINOMAS IN BCNS PATIENTS$0
U19 · FY2001 · CA
CORE--BIOSTATISTICAL$0
U19 · FY2001 · CA
CORE--BIOSTATISTICAL$0
U19 · FY2001 · CA
BASAL CELL CARCINOMA CHEMOPREVENTION IN BCNS PATIENTS$1,023,261
U19 · FY2000 · CA
CHEMOPREVENTION OF BASAL CELL CARCINOMAS IN BCNS PATIENTS$245,051
U19 · FY2000 · CA
DERMATOLOGY TRAINING GRANT - GRADUATE RESEARCH TRAINING$94,804
T32 · FY2000 · AR
CORE--BIOSTATISTICAL$74,357
U19 · FY2000 · CA